Black Rock Inc. Karyopharm Therapeutics Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,169,788 shares of KPTI stock, worth $2.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,169,788
Previous 9,447,678
55.86%
Holding current value
$2.54 Million
Previous $14.3 Million
74.57%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding KPTI
# of Institutions
94Shares Held
59.6MCall Options Held
547KPut Options Held
67K-
Vanguard Group Inc Valley Forge, PA7.65MShares$4.67 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.32MShares$3.86 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA4.91MShares$2.99 Million0.53% of portfolio
-
Morgan Stanley New York, NY3.51MShares$2.14 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.1MShares$1.89 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $48.7M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...